Delsmann B M, Hagena F W, Nerlich A, Dürr H R, Refior H J
Orthopädische Klinik und Poliklinik, Ludwig-Maximilians-Universität München-Klinikum Grosshadern.
Z Orthop Ihre Grenzgeb. 1996 Sep-Oct;134(5):435-40. doi: 10.1055/s-2008-1037434.
In a 52-year-old female patient and a 50-year-old patient with a malign tumor of the right distal femur (stage IIIb) respectively the left distal tibia (stage Ia according to Enneking), the extremely rare primary leiomyosarcoma of the bone was diagnosed. The mortality of the primary leiomyosarcoma of the bone is 50%, the mean survival time after diagnosis is 3.4 years. Diagnosis of a primary leiomyosarcoma of the bone is only possible after a secondary leiomyosarcoma has been excluded as well as by histopathological including immunohistochemical examination. The operative procedure is the therapy of choice. A neoadjuvant and/or adjuvant radio- or chemotherapy can be useful.
在一名52岁女性患者和一名50岁患者中,分别诊断出极为罕见的原发性骨平滑肌肉瘤,前者患有右股骨远端恶性肿瘤(Ⅲb期),后者患有左胫骨远端恶性肿瘤(根据恩宁克分期为Ⅰa期)。骨原发性平滑肌肉瘤的死亡率为50%,诊断后的平均生存时间为3.4年。只有在排除继发性平滑肌肉瘤以及通过包括免疫组织化学检查在内的组织病理学检查后,才能诊断骨原发性平滑肌肉瘤。手术是首选治疗方法。新辅助和/或辅助放疗或化疗可能有用。